Increased small dense LDL and decreased paraoxonase enzyme activity reveals formation of an atherogenic risk in streptozotocin-induced diabetic guinea pigs

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Aslan, Mutay ^a   Ozcan, Filiz ^a   Kucuksayan, Ertan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GUINEA PIG; LIPID ANALYSIS; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES;

EID: 84879342112     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/860190     Document Type: Article

References (38)

1. Campos H., Genest J. J. Jr., Blijlevens E., McNamara J. R., Jenner J. L., Ordovas J. M., Wilson P. W. F., Schaefer E. J., Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis and Thrombosis 1992 12 2 187 195 2-s2.0-0026526186
2. Genest J. Jr., McNamara J. R., Ordovas J. M., Jenner J. L., Silberman S. R., Anderson K. M., Wilson P. W. F., Salem D. N., Schaefer E. J., Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. Journal of the American College of Cardiology 1992 19 4 792 802 2-s2.0-0026572204
3. Chapman M. J., Laplaud P. M., Luc G., Forgez P., Bruckert E., Goulinet S., Lagrange D., Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. Journal of Lipid Research 1988 29 4 442 458 2-s2.0-0023927448
4. Austin M. A., King M. C., Vranizan K. M., Krauss R. M., Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990 82 2 495 506 2-s2.0-0025118667 (Pubitemid 20257828)
5. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G. R., Lupien P. J., Després J. P., Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997 95 1 69 75 2-s2.0-0031032723 (Pubitemid 27029945)
6. Wadwa R. P., Kinney G. L., Maahs D. M., Snell-Bergeon J., Hokanson J. E., Garg S. K., Eckel R. H., Rewers M., Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 2005 28 5 1051 1056 2-s2.0-18144426367 10.2337/diacare.28.5.1051 (Pubitemid 40616612)
7. Buse J. B., Ginsberg H. N., Bakris G. L., Clark N. G., Costa F., Eckel R., Fonseca V., Gerstein H. C., Grundy S., Nesto R. W., Pignone M. P., Plutzky J., Porte D., Redberg R., Stitzel K. F., Stone N. J., Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007 115 1 114 126 2-s2.0-33846083971 10.1161/CIRCULATIONAHA.106. 179294 (Pubitemid 46058619)
8. Fernandez M. L., Volek J. S., Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation. Nutrition and Metabolism 2006 3, article 17 2-s2.0-33646148733 10.1186/1743-7075-3-17
9. Qiu W. C., Wang Z. G., Wang W. G., Yan J., Zheng Q., Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro. Chinese Medical Journal 2008 121 13 1183 1188 2-s2.0-50549084928
10. LePard K. J., Choline acetyltransferase and inducible nitric oxide synthase are increased in myenteric plexus of diabetic guinea pig. Autonomic Neuroscience 2005 118 1-2 12 24 2-s2.0-15944383353 10.1016/j.autneu.2004.12.002 (Pubitemid 40431620)
11. DiMattio J., Alterations in ascorbic acid transport into the lens of streptozotocin- induced diabetic rats and guinea pigs. Investigative Ophthalmology and Visual Science 1992 33 10 2926 2935 2-s2.0-0026775963
12. Hoefner D. M., Hodel S. D., O'Brien J. F., Branum E. L., Sun D., Meissner I., McConnell J. P., Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system. Clinical Chemistry 2001 47 2 266 274 2-s2.0-0035134537 (Pubitemid 32142925)
13. 2 activity is a marker of small, dense LDL particles in human plasma. Clinical Chemistry 2005 51 12 2264 2273 2-s2.0-28044453286 10.1373/clinchem.2005.058404 (Pubitemid 41692569)
14. Szkudelski T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research 2001 50 6 537 546 2-s2.0-0035691617 (Pubitemid 34087272)
15. Luz Fernandez M., McNamara D. J., Dietary fat-mediated changes in hepatic apoprotein B/E receptor in the guinea pig: effect of polyunsaturated, monounsaturated, and saturated fat. Metabolism 1989 38 11 1094 1102 2-s2.0-0024424734 (Pubitemid 19273802)
16. Aggarwal D., West K. L., Zern T. L., Shrestha S., Vergara-Jimenez M., Fernandez M. L., JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs. BMC Cardiovascular Disorders 2005 5, article 30 2-s2.0-26844580001 10.1186/1471-2261-5-30 (Pubitemid 41461213)
17. Sirtori C. R., Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention. Expert Opinion on Investigational Drugs 2011 20 11 1543 1554
18. Ensign W. Y., McNamara D. J., Fernandez M. L., Exercise improves plasma lipid profiles and modifies lipoprotein composition in guinea pigs. Journal of Nutritional Biochemistry 2002 13 12 747 753 2-s2.0-0036903434 10.1016/S0955-2863(02)00219-X (Pubitemid 35463203)
19. Fernandez M. L., Wilson T. A., Conde K., Vergara-Jimenez M., Nicolosi R. J., Hamsters and guinea pigs differ in their plasma lipoprotein cholesterol distribution when fed diets varying in animal protein, soluble fiber, or cholesterol content. Journal of Nutrition 1999 129 7 1323 1332 2-s2.0-0033013642 (Pubitemid 29304981)
20. Manzato E., Zambon A., Zambon S., Nosadini R., Doria A., Marin R., Crepaldi G., Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients. Acta Diabetologica 1993 30 1 11 16 2-s2.0-0027489182 (Pubitemid 23286361)
21. Rosental S. B., Ferrari N., Ruiz M., Wikinski R. L., Alterations in dense LDL subfractions in normolipidemic IDDM patients. Acta Physiol Pharmacol Ther Latinoam 1996 46 185 192
22. Tall A. R., Plasma lipid transfer proteins. Journal of Lipid Research 1986 27 4 361 367 2-s2.0-0022692378
23. Niesor E. J., von der Mark E., Calabresi L., Lipid and apoprotein composition of HDL in partial or complete CETP deficiency. Current Vascular Pharmacology 2012 10 422 431
24. Hayashibe H., Asayama K., Nakane T., Kobayashi K., Amemiya S., Nakazawa S., Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus. Acta Paediatrica, International Journal of Paediatrics 1999 88 10 1067 1070 2-s2.0-0032831106 10.1080/08035259950168090 (Pubitemid 29489160)
25. Savel J., Lafitte M., Pucheu Y., Pradeau V., Tabarin A., Couffinhal T., Very low levels of HDL cholesterol and atherosclerosis, a variable relationship-a review of LCAT deficiency. Journal of Vascular Health and Risk Management 2012 8 357 361
26. De Vries R., Beusekamp B. J., Kerstens M. N., Groen A. K., Van Tol A., Dullaart R. P. F., A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre β -HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients. Scandinavian Journal of Clinical and Laboratory Investigation 2005 65 8 729 737 2-s2.0-28744452208 10.1080/00365510500375289 (Pubitemid 41759169)
27. Schernthaner G., Kostner G. M., Dieplinger H., Apolipoproteins (A-I, A-II, B) Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis 1983 49 3 277 293 2-s2.0-0021081287 (Pubitemid 14248755)
28. Valiyaveettil M., Alamneh Y., Rezk P., Biggemann L., Perkins M. W., Sciuto A. M., Doctor B. P., Nambiar M. P., Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs. Biochemical Pharmacology 2011 81 6 800 809 2-s2.0-79951953915 10.1016/j.bcp.2010.12.024
29. Durrington P. N., Mackness B., Mackness M. I., Paraoxonase and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 4 473 480 2-s2.0-0035048212 (Pubitemid 32323376)
30. Aviram M., Hardak E., Vaya J., Mahmood S., Milo S., Hoffman A., Billicke S., Draganov D., Rosenblat M., Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000 101 21 2510 2517 2-s2.0-0034738140 (Pubitemid 30366256)
31. Navab M., Berliner J. A., Subbanagounder G., Hama S., Lusis A. J., Castellani L. W., Reddy S., Shih D., Shi W., Watson A. D., Van Lenten B. J., Vora D., Fogelman A. M., HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 4 481 488 2-s2.0-0035045169 (Pubitemid 32323377)
32. Rosenblat M., Vaya J., Shih D., Aviram M., Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis 2005 179 1 69 77 2-s2.0-13844256208 10.1016/j.atherosclerosis.2004.10.028 (Pubitemid 40249787)
33. Mackness B., Hine D., McElduff P., Mackness M., High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease. Atherosclerosis 2006 186 2 396 401 2-s2.0-33646401361 10.1016/j.atherosclerosis. 2005.07.028
34. Asicioglu E., Yavuz D. G., Koc M., Ozben B., Yazici D., Deyneli O., Akalin S., Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus. European Journal of Endocrinology 2010 162 4 711 717 2-s2.0-77950334145 10.1530/EJE-09-0795
35. Aliciguzel Y., Ozen I., Aslan M., Karayalcin U., Activities of xanthine oxidoreductose and antioxidant enzymes in different tissues of diabetic rats. Journal of Laboratory and Clinical Medicine 2003 142 3 172 177 2-s2.0-0141921796 10.1016/S0022-2143(03)00110-0 (Pubitemid 37260470)
36. Ozcan F., Ozmen A., Akkaya B., Aliciguzel Y., Aslan M., Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes. Clinical and Experimental Medicine 2012 12 265 272
37. Aviram M., Rosenblat M., Billecke S., Erogul J., Sorenson R., Bisgaier C. L., Newton R. S., La Du B., Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biology and Medicine 1999 26 7-8 892 904 2-s2.0-0032921557 10.1016/S0891- 5849(98)00272-X (Pubitemid 29198362)
38. Shao B., Heinecke J. W., HDL, lipid peroxidation, and atherosclerosis. Journal of Lipid Research 2009 50 4 599 601 2-s2.0-67449123456 10.1194/jlr.E900001-JLR200